IMPEL PHARMACEUTICALS INC (IMPL) Stock Analyst Earnings Estimates
NASDAQ:IMPL - Nasdaq - US45258K1097 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 670K | 12.65M 1,788.06% | 29.274M 131.42% | 51.918M 77.35% | 82.314M 58.55% | 239.7M 191.20% | 300.9M 25.53% | 351.9M 16.95% | 402.9M 14.49% | 453.9M 12.66% | ||
| EBITDA YoY % growth | -44.25M -8.32% | -70.4M -59.10% | -81.88M -16.31% | -70.278M 14.17% | -48.144M 31.49% | -31.008M 35.59% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -45.33M -9.04% | -71.49M -57.71% | -83.08M -16.21% | -71.094M 14.43% | -49.368M 30.56% | -32.232M 34.71% | 81.396M 352.53% | 123.22M 51.38% | 156.37M 26.90% | 189.52M 21.20% | 222.67M 17.49% | |
| Operating Margin | N/A | -10,670.15% | -656.76% | -242.86% | -95.09% | -39.16% | 33.96% | 40.95% | 44.44% | 47.04% | 49.06% | |
| EPS YoY % growth | N/A | -3.95 | -4.54 -14.94% | -1.61 64.50% | -0.89 44.94% | -0.59 33.33% | 2.55 531.03% | 2.86 12.00% | 3.57 25.00% | 4.28 20.00% | 4.95 15.48% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 77.92% | -0.40 68.68% | -0.37 57.30% | -0.15 73.62% | -0.14 33.33% |
| Revenue Q2Q % growth | 9.894M 97.49% | 10.2M 133.41% | 12.24M 86.02% | 13.77M 68.75% | 15.708M 58.76% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.313M 54.17% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.58 55.73% | -0.37 | -0.21 | -57.95% |
| Q2 2023 Q2Q % growth | -0.86 21.10% | -0.67 | -0.19 | -28.72% |
| Q1 2023 Q2Q % growth | -1.27 -8.55% | -0.92 | -0.35 | -38.34% |
| Q4 2022 Q2Q % growth | -0.97 9.35% | -1.14 | 0.17 | 14.63% |
| Q3 2022 Q2Q % growth | -1.31 -5.65% | -1.02 | -0.29 | -28.11% |
| Q2 2022 Q2Q % growth | -1.09 0.91% | -1.07 | -0.02 | -1.45% |
| Q1 2022 Q2Q % growth | -1.17 -116.67% | -1.07 | -0.10 | -8.90% |
| Q4 2021 Q2Q % growth | -1.07 | -0.89 | -0.18 | -20.12% |
| Q3 2021 Q2Q % growth | -1.24 | -0.77 | -0.48 | -62.09% |
| Q2 2021 Q2Q % growth | -1.10 | -0.61 | -0.49 | -79.74% |
| Q1 2021 Q2Q % growth | -0.54 | -0.95 | 0.41 | 43.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 164.94% | 8.16M | % | |
| Q2 2023 Q2Q % growth | 6.58M 135.00% | 6.63M | -50K | -0.75% |
| Q1 2023 Q2Q % growth | 4.37M 148.30% | 5.848M | -1.478M | -25.27% |
| Q4 2022 Q2Q % growth | 5.01M 763.79% | 5.065M | -55K | -1.09% |
| Q3 2022 Q2Q % growth | 3.08M 3,322.22% | 5.942M | -2.862M | -48.17% |
| Q2 2022 Q2Q % growth | 2.8M | 3.91M | -1.11M | -28.39% |
| Q1 2022 Q2Q % growth | 1.76M | 1.836M | -76K | -4.14% |
| Q4 2021 Q2Q % growth | 580K | 1.357M | -777K | -57.26% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 99900% | 0% | 0% |